| Financial Year |
March 31 2023 |
| Monetary Funds |
7,815,985,135.61 |
| Held-for-trading Financial Assets |
58,106,224.43 |
| Notes Receivable |
-- |
| Accounts Receivable |
940,746,088.72 |
| Advances to Suppliers |
114,726,046.39 |
| Other Receivables |
143,988,526.28 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
225,055,949.16 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
122,332,638.31 |
| Total Current Assets |
9,666,900,022.50 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
102,154,649.31 |
| Investment Properties |
87,184,974.09 |
| Fixed Assetes |
3,588,943,925.56 |
| Under-construction Projects |
84,402,144.97 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
597,042,558.34 |
| R&D expenses |
6,843,606.25 |
| Goodwill |
57,539,320.06 |
| Long-Term Deferred and Prepaid Expenses |
12,669,976.20 |
| Deferred Income Tax Assets |
49,985,617.71 |
| Other Non-Current Assets |
31,346,950.65 |
| Sub-Total of Non-Current Assets |
7,380,475,382.29 |
| Total Assets |
17,047,375,404.79 |
| Short-Term Loans |
2,059,870,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
395,260,988.40 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
5,057,400.80 |
| Taxes Payable |
250,080,015.01 |
| Interest Payable |
-- |
| Dividend Payable |
1,200,000.00 |
| Other payables |
108,628,571.01 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
224,311,919.05 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
3,313,515,362.15 |
| Long-term Loans |
60,955,982.56 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
65,538,808.08 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,446,993,585.72 |
| Total Liabilities |
4,760,508,947.87 |
| Paid-In Capital(Or Share Stock) |
2,288,119,475.00 |
| Capital Surplus |
1,940,848,794.94 |
| Surplus Reserve |
471,962,063.09 |
| LESS:Treasury Stock |
250,105,827.12 |
| Undistributed Profits |
6,651,846,968.29 |
| Minority Stockholder's Interest |
1,027,744,428.63 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
11,259,122,028.29 |
| Owner's Equity（Stockholder's Equity） |
12,286,866,456.92 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
17,047,375,404.79 |
